Ad
related to: exact sciences cologuard order form- Cologuard® FAQs
Find Anwers To The Most
Commonly Asked Questions.
- Cologuard® Patient Site
Request A Cologuard® Prescription
From Your Provider Or Online Today.
- Contact Us
Get Connected With A Representative
Today For Cologuard® HCP Support.
- How To Order
Cologuard® Makes Ordering Simple,
Learn More About Ordering Options.
- Risk Info And Indications
See Important Risk Information
And Indications For Cologuard®.
- Eligible Patients
Screen Average-Risk Patients For
Colorectal Cancer Starting At 45.
- Cologuard® FAQs
Search results
Results From The WOW.Com Content Network
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown ...
Exact Sciences' stool test Cologuard had a 92.3% sensitivity rate. Colorectal cancer occurs in about 150,000 patients in the U.S. annually and is the second-leading cause of cancer fatalities in ...
Guardant's application for Shield was based on a study that showed the test detected 83% of colorectal cancers, while Exact's Cologuard had 92.3% sensitivity rate, according to the FDA's documents.
Top-Line Data Show Exact Sciences' Cologuard Test Demonstrates 92 Percent Sensitivity in the Detection of Colorectal Cancer All endpoints achieved in 10,000-patient trial of non-invasive ...
Year-to-date gains of 25% don't really tell the full story for molecular diagnostics company Exact Sciences . There have been plenty of big ups and downs to get to those 25% gains. Since late ...
You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.
Exact Sciences (EXAS) reaches a co-promotion agreement with Pfizer to commercialize its non-invasive screening test for colorectal cancer, Cologuard. The stock rallies following this news.
For premium support please call: 800-290-4726 more ways to reach us
Ad
related to: exact sciences cologuard order form